FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Innovations in Care

We provide programs and services that transform the lives of people affected by neuromuscular disease.

What Becker natural history studies tell us about Becker disease progression

January 22nd, 2026
1:30 PM in Arizona
Live, Virtual Webinar

Please join Dr. Amit Sachdev from Michigan State University
and Dr. Joanne Donovan from Edgewise Therapeutics to hear about ongoing learnings from Becker Natural History studies, which track how Becker disease progresses over time. The webinar will highlight new insights into Becker disease course and how these learnings can inform proactive Becker clinical care and therapy development for Becker.

Register

Faculty: 
Dr. Amit Sachdev

Michigan State University

Dr. Joanne Donovan

Edgewise Therapeutics


Thank you to our supporter:

Edgewise Therapeutics